nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioproperazine—ADRA1B—polycystic ovary syndrome	0.472	0.598	CbGaD
Thioproperazine—ADRA1A—polycystic ovary syndrome	0.318	0.402	CbGaD
Thioproperazine—SLC22A1—Metformin—polycystic ovary syndrome	0.0944	1	CbGbCtD
Thioproperazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.000501	0.0832	CrCbGaD
Thioproperazine—Nefazodone—ADRA1B—polycystic ovary syndrome	0.000357	0.0593	CrCbGaD
Thioproperazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.000322	0.0534	CrCbGaD
Thioproperazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000302	0.0501	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.000258	0.0428	CrCbGaD
Thioproperazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000257	0.0427	CrCbGaD
Thioproperazine—Quetiapine—ADRA1D—polycystic ovary syndrome	0.000243	0.0404	CrCbGaD
Thioproperazine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.000242	0.0401	CrCbGaD
Thioproperazine—Nefazodone—ADRA1A—polycystic ovary syndrome	0.00024	0.0399	CrCbGaD
Thioproperazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000231	0.0383	CrCbGaD
Thioproperazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000224	0.0371	CrCbGaD
Thioproperazine—Trazodone—ADRA1A—polycystic ovary syndrome	0.000222	0.0369	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.00022	0.0365	CrCbGaD
Thioproperazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.000217	0.036	CrCbGaD
Thioproperazine—Quetiapine—ADRA1B—polycystic ovary syndrome	0.000208	0.0344	CrCbGaD
Thioproperazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000196	0.0325	CrCbGaD
Thioproperazine—Promazine—ADRA1B—polycystic ovary syndrome	0.000191	0.0317	CrCbGaD
Thioproperazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.000173	0.0288	CrCbGaD
Thioproperazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.000168	0.0279	CrCbGaD
Thioproperazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.000167	0.0277	CrCbGaD
Thioproperazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000155	0.0258	CrCbGaD
Thioproperazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.000148	0.0246	CrCbGaD
Thioproperazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000146	0.0242	CrCbGaD
Thioproperazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000144	0.0239	CrCbGaD
Thioproperazine—Quetiapine—ADRA1A—polycystic ovary syndrome	0.00014	0.0232	CrCbGaD
Thioproperazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000128	0.0213	CrCbGaD
Thioproperazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.000113	0.0188	CrCbGaD
Thioproperazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.000112	0.0187	CrCbGaD
Thioproperazine—DRD1—Signaling Pathways—PGR—polycystic ovary syndrome	1.75e-05	0.000159	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	1.74e-05	0.000159	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.73e-05	0.000157	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.72e-05	0.000157	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—SCT—polycystic ovary syndrome	1.71e-05	0.000156	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.71e-05	0.000156	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Thioproperazine—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Thioproperazine—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	1.69e-05	0.000155	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.69e-05	0.000154	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	1.69e-05	0.000154	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.68e-05	0.000154	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.68e-05	0.000153	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.66e-05	0.000151	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.66e-05	0.000151	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.64e-05	0.000149	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.63e-05	0.000149	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	1.63e-05	0.000149	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—GHRL—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—PLAT—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	1.62e-05	0.000148	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.62e-05	0.000147	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.61e-05	0.000147	CbGpPWpGaD
Thioproperazine—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.61e-05	0.000147	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.61e-05	0.000146	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.6e-05	0.000146	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Thioproperazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.59e-05	0.000145	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—LHB—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.57e-05	0.000143	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.56e-05	0.000142	CbGpPWpGaD
Thioproperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.55e-05	0.000142	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.55e-05	0.000141	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.55e-05	0.000141	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.54e-05	0.000141	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.54e-05	0.00014	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	1.53e-05	0.00014	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.52e-05	0.000138	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.51e-05	0.000138	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	1.51e-05	0.000138	CbGpPWpGaD
Thioproperazine—DRD1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.5e-05	0.000137	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.5e-05	0.000137	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	1.49e-05	0.000136	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.49e-05	0.000136	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	1.49e-05	0.000135	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.47e-05	0.000134	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.47e-05	0.000134	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.45e-05	0.000132	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.44e-05	0.000131	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	1.43e-05	0.00013	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.42e-05	0.00013	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—PRL—polycystic ovary syndrome	1.42e-05	0.000129	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.42e-05	0.000129	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—INSR—polycystic ovary syndrome	1.4e-05	0.000128	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.4e-05	0.000127	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.4e-05	0.000127	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.37e-05	0.000125	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.34e-05	0.000123	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.33e-05	0.000122	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.33e-05	0.000122	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.32e-05	0.000121	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	1.32e-05	0.00012	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.31e-05	0.00012	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.3e-05	0.000118	CbGpPWpGaD
Thioproperazine—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.29e-05	0.000118	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.28e-05	0.000117	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.28e-05	0.000117	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.28e-05	0.000116	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.27e-05	0.000116	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.25e-05	0.000114	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.24e-05	0.000113	CbGpPWpGaD
Thioproperazine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.22e-05	0.000111	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.21e-05	0.00011	CbGpPWpGaD
Thioproperazine—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.2e-05	0.00011	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	1.19e-05	0.000108	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.19e-05	0.000108	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.17e-05	0.000107	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.17e-05	0.000107	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.17e-05	0.000107	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.17e-05	0.000106	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.16e-05	0.000105	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.15e-05	0.000105	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Thioproperazine—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.14e-05	0.000104	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Thioproperazine—HTR2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.1e-05	0.0001	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.1e-05	0.0001	CbGpPWpGaD
Thioproperazine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.09e-05	9.98e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.08e-05	9.85e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.07e-05	9.79e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.07e-05	9.78e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.07e-05	9.78e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	1.07e-05	9.76e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.06e-05	9.69e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.06e-05	9.63e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.05e-05	9.6e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.04e-05	9.49e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.03e-05	9.43e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.03e-05	9.41e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.03e-05	9.4e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.02e-05	9.31e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.02e-05	9.31e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.02e-05	9.26e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.02e-05	9.25e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1e-05	9.14e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	1e-05	9.13e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.99e-06	9.11e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IRS2—polycystic ovary syndrome	9.99e-06	9.11e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.94e-06	9.06e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.78e-06	8.92e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—LEP—polycystic ovary syndrome	9.77e-06	8.91e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—TH—polycystic ovary syndrome	9.75e-06	8.88e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.73e-06	8.87e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.55e-06	8.71e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.48e-06	8.64e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.42e-06	8.58e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.26e-06	8.45e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.07e-06	8.27e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.97e-06	8.18e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	8.91e-06	8.13e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.83e-06	8.05e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	8.8e-06	8.03e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.72e-06	7.95e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.66e-06	7.9e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.64e-06	7.88e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.59e-06	7.83e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.48e-06	7.73e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.41e-06	7.66e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—POMC—polycystic ovary syndrome	8.4e-06	7.66e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—INS—polycystic ovary syndrome	8.35e-06	7.61e-05	CbGpPWpGaD
Thioproperazine—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.3e-06	7.57e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.18e-06	7.46e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	8.12e-06	7.4e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.08e-06	7.36e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.07e-06	7.36e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	8.01e-06	7.3e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	8e-06	7.3e-05	CbGpPWpGaD
Thioproperazine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	7.96e-06	7.26e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—GNAS—polycystic ovary syndrome	7.96e-06	7.25e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.67e-06	6.99e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.58e-06	6.91e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.54e-06	6.88e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.5e-06	6.84e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.42e-06	6.77e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	7.38e-06	6.73e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.27e-06	6.62e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	7.26e-06	6.62e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.22e-06	6.58e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	7.18e-06	6.55e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	7.18e-06	6.55e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.14e-06	6.51e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.11e-06	6.48e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.95e-06	6.33e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.94e-06	6.33e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	6.88e-06	6.27e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	6.84e-06	6.23e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.7e-06	6.11e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.61e-06	6.03e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.61e-06	6.03e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.6e-06	6.01e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.58e-06	6e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.48e-06	5.91e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.34e-06	5.78e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	6.34e-06	5.78e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	6.3e-06	5.75e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.28e-06	5.73e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	6.24e-06	5.69e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	6.2e-06	5.66e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.18e-06	5.63e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.11e-06	5.57e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.1e-06	5.56e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.09e-06	5.56e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	6.07e-06	5.54e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	6e-06	5.47e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	6e-06	5.47e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.88e-06	5.36e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.87e-06	5.35e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.79e-06	5.28e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.7e-06	5.2e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.58e-06	5.09e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.43e-06	4.95e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—POMC—polycystic ovary syndrome	5.36e-06	4.88e-05	CbGpPWpGaD
Thioproperazine—ALB—Metabolism—INS—polycystic ovary syndrome	5.33e-06	4.86e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.31e-06	4.84e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.28e-06	4.81e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.06e-06	4.61e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.66e-06	4.25e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.59e-06	4.18e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.54e-06	4.14e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.49e-06	4.1e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.32e-06	3.94e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.98e-06	3.63e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.92e-06	3.57e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.84e-06	3.5e-05	CbGpPWpGaD
Thioproperazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	3.65e-06	3.33e-05	CbGpPWpGaD
Thioproperazine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.14e-06	2.86e-05	CbGpPWpGaD
Thioproperazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	2.99e-06	2.72e-05	CbGpPWpGaD
Thioproperazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	2.75e-06	2.51e-05	CbGpPWpGaD
Thioproperazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.71e-06	2.47e-05	CbGpPWpGaD
Thioproperazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.65e-06	2.42e-05	CbGpPWpGaD
